The FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...

Discover phases of acute ischemic stroke care, from rapid recognition to long-term recovery strategies that neurologists use ...

Eylea is used to treat diseases such as neovascular, or "wet," age-related macular degeneration, macular edema ... the $1.16 ...

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

well below the $1.16 billion consensus estimate of analysts polled by Visible Alpha. Its total revenue also trailed estimates, falling 4% year-over-year at $3.03 billion versus expectations of $3. ...

The Company announced a 10-year agreement with FUJIFILM Diosynth Biotechnologies (Fujifilm) to manufacture and supply Regeneron's commercial bulk drug product at Fujifilm's North Carolina campus. The ...

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...

Altitude is defined on the following scale High (8,000 - 12,000 feet [2,438 - 3,658 meters ... This process is known as acclimatization and generally takes 1-3 days at that altitude. For example, if ...